After developing symptomatic severe aortic stenosis (SSAS), the average patient survival is two years without treatment. Transcatheter Aortic Valve Replacement (TAVR) provides a minimally invasive option to restore heart valve function for eligible SSAS patients.

Designed for the MedTech community, this downloadable infographic outlines the remarkable evolution of TAVR technology from 2007 through today. It highlights major milestones in SSAS treatment and will help you discover:

• How self-expanding TAVR systems are continuing to revolutionize aortic heart valve replacement for SSAS patients
• How the latest TAVR advancements are allowing for greater precision and control throughout procedures
• Why TAVR cases are now outpacing surgical aortic valve replacement for SSAS

​